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Cardiac hypertrophy is an adaptive
response to haemodynamic stress. Pressure
and/or volume overload in hypertension,
myocardial infarction (MI) and valvular
heart disease are pathological stresses that
lead to left-ventricular (LV) dilatation
and/or wall thickening. While in the
short term compensatory mechanisms
maintain cardiac output, sustained hyper-
trophic responses can lead to maladaptive
remodelling, predisposing to cardiac
arrhythmias and heart failure.
Physical exercise and pregnancy are
examples of physiological stress. The
nature of the exercise determines the
balance between dilatation and increased
wall thickness, producing so-called physio-
logical hypertrophy. Although similar
degrees of LV hypertrophy are achieved
in pathological and physiological hyper-
trophy, physiological hypertrophy generally
fails to produce adverse consequences like
ventricular arrhythmias (Viitasalo et al.
1982; Bifﬁ et al. 2008).
So, what makes the consequences of
physiological remodelling different from
those of pathological remodelling?
Mechanisms of stress-related cardiac
remodelling
Stress alters cardiac gene expression,
remodelling the structural, functional
and electrophysiological properties of the
heart (Nattel et al. 2010). Remodelling
affects cardiomyocytes, interstitial matrix,
ﬁbroblasts and the coronary vasculature,
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butthemolecularandcellulareventsunder-
lying decompensation are poorly under-
stood (Armoundas et al. 2001).
Heart failure is associated with
upregulation of myocardial fetal and
stretched-response genes (Butter et al.
2008), and numerous targets and
regulators controlling hypertrophy,
including phosphoinositol-3-kinase
(PI3K), calcineurin, microRNAs and
gene mutations are recognized (Rohini
et al. 2010). Alterations in ion channels,
connexins and ion transporters lead to
arrhythmogenesis(Natteletal.2010;Roden
& Kupershmidt, 1999). The characteristic
changes in cells and tissues from failing
hearts are action potential (AP) duration
(APD) prolongation and conduction
slowing (Aiba & Tomaselli, 2010). APD
prolongation results principally from K+
current downregulation and typically
leads to arrhythmias by inducing after-
depolarizations (Nattel et al. 2007).
Heart failure also profoundly dysregulates
Ca2+-handling genes and proteins,
increasing Na+/Ca2+ exchange, decreasing
sarcoplasmic reticulum Ca2+-ATPase
and impairing Ca2+-release channel
(RyR2a) function (Nattel et al. 2007).
The mechanisms underlying ion channel
remodelling in physiological hypertrophy
are much less well understood. Regional
differences in K+ current adaptation have
been suggested (Stones et al. 2009).
In this issue of The Journal of Physio-
logy,Y a n get al. (2010) investigate the
ionic remodelling caused by physio-
logical hypertrophy in two mouse models.
They show that mice subjected to a
swimming programme develop signiﬁcant
ionic remodelling. With the hypertrophic
process almost all currents increase sub-
stantially in amplitude, but because of
parallel increases in cell size current
density, the primary factor controlling
transmembrane voltage (Nattel, 2008),
is unaltered or moderately increased.
Because relatively similar increases occur in
repolarizing K+ currents and depolarizing
Ca2+ current, repolarization indices remain
unchanged. Similar results occur in a
t r a n s g e n i cm o d e lo fp h y s i o l o g i c a lh y p e r -
trophy, constitutively-active PI3K-p110a
overexpression.
Different cardiac PI3K isoforms have
distinct roles (Damilano et al. 2010).
PI3K mediates cardiac hypertrophy, both
in physiological (through PI3Kα,e . g .
in exercise training) and pathological
(through PI3Kγ,e . g .i np r e s s u r eo v e r -
load)conditions.Physiologicalhypertrophy
is mediated primarily by the insulin-like
growth factor-1 pathway, coupled with
PI3Kα, and is triggered by tyrosine-kinase
receptors. PI3Kα protects from fetal gene
re-expression. PI3Kα inhibits apoptotic cell
deathbyactivatingAkt(Dhanasekaranetal.
2008), which also suppresses pathological
signalling cascades (Owen et al. 2009).
The results of Yang et al. nicely link
the cardioprotective effect of PI3Kα to
physiological ion current remodelling.
In contrast, G protein-coupled receptor
(GPCR) stimulation by angiotensin II,
endothelin-1 and catecholamines activates
PI3Kγ, leading to pathological hypertrophy
(Owen et al. 2009).
Clinical relevance of understanding
electrical remodelling in
physiological hypertrophy
Sudden arrhythmic death is a major cause
of mortality in patients with heart failure,
and repolarization abnormalities are an
important predictor (Galinier et al. 1998).
The observations of Yang et al.a g r e ew i t h
thelackofrepolarizationchangesinhealthy
individuals subjected to light exercise
(Rajappan et al. 2003). Correspondingly,
ventricular arrhythmias are not related to
LVhypertrophyinathletes(Bifﬁetal.2008).
The benign properties of physiological
ion channel remodelling raise the attractive
possibility of counteracting pathological
electrophysiological adaptation and
decreasing arrhythmia risk in heart disease
patients by means of exercise training.
Lachance et al. (2009) demonstrated a
lower sudden-death rate in rats with heart
failure and LV hypertrophy who were
submitted to treadmill training. In rats
with previous MI, normalization of APD
abnormalities by exercise training has been
reported (Zhang et al. 2001), although
this is not a uniform ﬁnding (Bito et al.
2010).Exercisetrainingcanfavourablyalter
signalling pathways involved in adverse
cardiac remodelling (Guasch et al. 2010),
and repolarization abnormalities in heart
failure patients are improved by aerobic
exercise training (Ali et al. 1999).
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Knowledge of the pathways involved
in physiological versus pathological
remodelling may help in designing
innovative therapeutic paradigms.
Activation of the PI3Kα system,
demonstrated by Yang et al. to be central
to the balanced electrical remodelling seen
with physiological hypertrophy, could be
an interesting strategy for preventing the
pathological electrical remodelling that
leads to sudden death in heart disease
patients. Possible approaches could run
from the simplest physiological methods
(e.g. exercise training) to small-molecule
activators or even gene-therapy techniques.
Further comparisons between signalling
pathways in pathological versus physio-
logicalremodellingmayprovideindications
of additional promising molecular targets
for sudden-death prevention.
Yang etal.carefully studied remodelling of
ionic currents and APs by exercise training.
However, arrhythmogenesis is determined
not only by cardiomyocyte cellular electro-
physiology, but also by additional factors
suchascardiacstructure(Burstein&Nattel,
2008;Safﬁtzetal.2010)andautonomictone
(Chenetal.2007).Thesefactorsmayalsobe
inﬂuencedbyexercisetraining,andinsome
circumstances may not have totally benign
consequences. Right-ventricular structural
remodelling may contribute to an increased
incidence of ventricular arrhythmias in
trained endurance athletes (Benito et al.
2010). While protecting from ventricular
arrhythmias in ischaemic myocardium
(Tsutsumi et al. 2008), exercise-induced
autonomic-tone changes may contribute
to the well-recognized occurrence of atrial
ﬁbrillation in otherwise-healthy endurance
athletes (Benito et al. 2009).
Finally, it may not be accurate to
assume that all forms of ‘physiological
remodelling’ are necessarily equivalent.
The type and intensity of exercise
training may be of critical importance
for ion-channel remodelling. Swimming
and treadmill training induce differential
responses in rats, with swimming causing a
greater resting bradycardia and increased
cardiac-tissueadrenalineandnoradrenaline
concentrations compared to running
(Geenen et al. 1988). Unlike the paradigm
studied by Yang et al., high-intensity
exercise training can produce QT-interval
prolongation reﬂecting ventricular
repolarization delays (Sharma et al. 1999).
In conclusion, the elegant study by
Yang et al. provides important and
clinically relevant information about
the electrophysiological changes and
cell-signalling events induced by physio-
logical remodelling. At the same time their
work raises thought-provoking questions
that will need to be addressed in future
research.
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